Literature DB >> 17233764

An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae.

Bruno Almeida1, Belém Sampaio-Marques, Joana Carvalho, Manuel T Silva, Cecília Leão, Fernando Rodrigues, Paula Ludovico.   

Abstract

Ciclopirox olamine (CPO), a fungicidal agent widely used in clinical practice, induced in Saccharomyces cerevisiae an active cell death (ACD) process characterized by changes in nuclear morphology and chromatin condensation associated with the appearance of a population in the sub-G(0)/G(1) cell cycle phase and an arrest delay in the G(2)/M phases. This ACD was associated neither with intracellular reactive oxygen species (ROS) signaling, as revealed by the use of different classes of ROS scavengers, nor with a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-positive phenotype. Furthermore, CPO-induced cell death seems to be dependent on unknown protease activity but independent of the apoptotic regulators Aif1p and Yca1p and of autophagic pathways involving Apg5p, Apg8p and Uth1p. Our results show that CPO triggers in S. cerevisiae an atypical nonapoptotic, nonautophagic ACD with as yet unknown regulators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17233764     DOI: 10.1111/j.1567-1364.2006.00188.x

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  11 in total

1.  Isc1p plays a key role in hydrogen peroxide resistance and chronological lifespan through modulation of iron levels and apoptosis.

Authors:  Teresa Almeida; Marta Marques; Dominik Mojzita; Maria A Amorim; Rui D Silva; Bruno Almeida; Pedro Rodrigues; Paula Ludovico; Stefan Hohmann; Pedro Moradas-Ferreira; Manuela Côrte-Real; Vítor Costa
Journal:  Mol Biol Cell       Date:  2007-12-27       Impact factor: 4.138

2.  The antitumor activity of the fungicide ciclopirox.

Authors:  Hongyu Zhou; Tao Shen; Yan Luo; Lei Liu; Wenxing Chen; Baoshan Xu; Xiuzhen Han; Jia Pang; Chantal A Rivera; Shile Huang
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

3.  Accumulation of non-superoxide anion reactive oxygen species mediates nitrogen-limited alcoholic fermentation by Saccharomyces cerevisiae.

Authors:  Ana Mendes-Ferreira; Belém Sampaio-Marques; Catarina Barbosa; Fernando Rodrigues; Vítor Costa; Arlete Mendes-Faia; Paula Ludovico; Cecília Leão
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

4.  Nitric oxide signaling is disrupted in the yeast model for Batten disease.

Authors:  Nuno S Osório; Agostinho Carvalho; Agostinho J Almeida; Sérgio Padilla-Lopez; Cecília Leão; João Laranjinha; Paula Ludovico; David A Pearce; Fernando Rodrigues
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

5.  New Insights Regarding Yeast Survival following Exposure to Liposomal Amphotericin B.

Authors:  Rita Teixeira-Santos; Elisabete Ricardo; Susana Gomes Guerreiro; Sofia Costa-de-Oliveira; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

6.  Caspofungin kills Candida albicans by causing both cellular apoptosis and necrosis.

Authors:  Binghua Hao; Shaoji Cheng; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

Review 7.  Exploitation of genomics in fungicide research: current status and future perspectives.

Authors:  Hans J Cools; Kim E Hammond-Kosack
Journal:  Mol Plant Pathol       Date:  2012-11-16       Impact factor: 5.663

Review 8.  Guidelines and recommendations on yeast cell death nomenclature.

Authors:  Didac Carmona-Gutierrez; Maria Anna Bauer; Andreas Zimmermann; Andrés Aguilera; Nicanor Austriaco; Kathryn Ayscough; Rena Balzan; Shoshana Bar-Nun; Antonio Barrientos; Peter Belenky; Marc Blondel; Ralf J Braun; Michael Breitenbach; William C Burhans; Sabrina Büttner; Duccio Cavalieri; Michael Chang; Katrina F Cooper; Manuela Côrte-Real; Vítor Costa; Christophe Cullin; Ian Dawes; Jörn Dengjel; Martin B Dickman; Tobias Eisenberg; Birthe Fahrenkrog; Nicolas Fasel; Kai-Uwe Fröhlich; Ali Gargouri; Sergio Giannattasio; Paola Goffrini; Campbell W Gourlay; Chris M Grant; Michael T Greenwood; Nicoletta Guaragnella; Thomas Heger; Jürgen Heinisch; Eva Herker; Johannes M Herrmann; Sebastian Hofer; Antonio Jiménez-Ruiz; Helmut Jungwirth; Katharina Kainz; Dimitrios P Kontoyiannis; Paula Ludovico; Stéphen Manon; Enzo Martegani; Cristina Mazzoni; Lynn A Megeney; Chris Meisinger; Jens Nielsen; Thomas Nyström; Heinz D Osiewacz; Tiago F Outeiro; Hay-Oak Park; Tobias Pendl; Dina Petranovic; Stephane Picot; Peter Polčic; Ted Powers; Mark Ramsdale; Mark Rinnerthaler; Patrick Rockenfeller; Christoph Ruckenstuhl; Raffael Schaffrath; Maria Segovia; Fedor F Severin; Amir Sharon; Stephan J Sigrist; Cornelia Sommer-Ruck; Maria João Sousa; Johan M Thevelein; Karin Thevissen; Vladimir Titorenko; Michel B Toledano; Mick Tuite; F-Nora Vögtle; Benedikt Westermann; Joris Winderickx; Silke Wissing; Stefan Wölfl; Zhaojie J Zhang; Richard Y Zhao; Bing Zhou; Lorenzo Galluzzi; Guido Kroemer; Frank Madeo
Journal:  Microb Cell       Date:  2018-01-01

9.  Response of Saccharomyces cerevisiae to the stimulation of lipopolysaccharide.

Authors:  Lulu Shen; Ye Li; Linghuo Jiang; Xiaoyuan Wang
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

10.  Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial.

Authors:  Deepti Saxena; Michael Spino; Fernando Tricta; John Connelly; Bernadette M Cracchiolo; Axel-Rainer Hanauske; Darlene D'Alliessi Gandolfi; Michael B Mathews; Jonathan Karn; Bart Holland; Myung Hee Park; Tsafi Pe'ery; Paul E Palumbo; Hartmut M Hanauske-Abel
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.